Propanc Biopharma, Inc. (Nasdaq: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing novel treatments for recurrent and ...

Q3 2025 Earnings Call Transcript November 12, 2025 Innoviz Technologies Ltd. reports earnings inline with expectations. Reported EPS is $-0.08 EPS, expectations were $-0.08. Operator: Ladies and ...

Given the success of Research Topic <a href=" in Targeted Therapy and Biomarker Research for Endocrine-Related Cancers and ...

For rare diseases, AI-driven repurposing fills a critical gap. With more than 7000 rare diseases and only a small percentage ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ('Adial” or the 'Company”), a clinical-stage biopharmaceutical company focused on ...

Olympe Imagerie to deploy Nanox.ARC at Paris-area Hospital Privé Jacques Cartier MASSY for lung cancer screening applications ...

When people trust you, they follow your work, not your trends. They read your words with intention. They root for your ...

November 14, 2025 / 5E Advanced Materials, Inc. ("5E" or the "Company") (Nasdaq:FEAM)(ASX:5EA), a development stage company ...

Q3 2025 Earnings Call November 13, 2025 5:00 PM ESTCompany ParticipantsKelly Goodman - Interim CEO & Corporate ...

Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary endpoints with potential of ...

The New York State Federation of Taxi Drivers protested outside of Gov. Kathy Hochul's Manhattan office, asserting that ...

Capital raised -- $17.1 million in new funding was secured, including a $13 million post-quarter investment from a leading ...